These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 25755050)

  • 1. N-terminal guanidinylation of the cyclic 1,4-ureido-deltorphin analogues: the synthesis, receptor binding studies, and resistance to proteolytic digestion.
    Bańkowski K; Michalak OM; Leśniak A; Filip KE; Cmoch P; Szewczuk Z; Stefanowicz P; Izdebski J
    J Pept Sci; 2015 Jun; 21(6):467-75. PubMed ID: 25755050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological activity and resistance to proteolytic digestion of new cyclic dermorphin/deltorphin analogues.
    Bańkowski K; Witkowska E; Michalak OM; Sidoryk K; Szymanek E; Antkowiak B; Paluch M; Filip KE; Cebrat M; Setner B; Szewczuk Z; Stefanowicz P; Cmoch P; Izdebski J
    Eur J Med Chem; 2013 May; 63():457-67. PubMed ID: 23523659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and binding properties of radioiodinated analogues of dermorphin and deltorphin with high specificity for the mu- and delta-opioid receptors.
    Gaudriault G; Zsürger N; Vincent JP
    J Neurochem; 1997 Feb; 68(2):813-9. PubMed ID: 9003073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6.
    Biondi L; Giannini E; Filira F; Gobbo M; Marastoni M; Negri L; Scolaro B; Tomatisc R; Rocchi R
    J Pept Sci; 2003 Oct; 9(10):638-48. PubMed ID: 14620129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides.
    Breveglieri A; Guerrini R; Salvadori S; Bianchi C; Bryant SD; Attila M; Lazarus LH
    J Med Chem; 1996 Feb; 39(3):773-80. PubMed ID: 8576920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and binding properties of deltorphin I analogues containing (R) and (S)-alpha-hydroxymethylnaphtylalanine.
    Olma A; Gniadzik A; Lipkowski AW; Lachwa M
    Acta Biochim Pol; 2001; 48(4):1165-8. PubMed ID: 11995986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogues of deltorphin I containing conformationally restricted amino acids in position 2: structure and opioid activity.
    Lasota A; Frączak O; Leśniak A; Muchowska A; Lipkowski AW; Nowakowski M; Ejchart A; Olma A
    J Pept Sci; 2015 Feb; 21(2):120-5. PubMed ID: 25558014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of cyclic deltorphins and dermenkephalins with a disulfide bridge leads to analogues with high selectivity for delta-opioid receptors.
    Misicka A; Lipkowski AW; Horvath R; Davis P; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1994 Jan; 37(1):141-5. PubMed ID: 8289187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformation-activity relationships of cyclo-constrained mu/delta opioid agonists derived from the N-terminal tetrapeptide segment of dermorphin/deltorphin.
    Ciarkowski J; Czaplewski C; Łuczak S; Rodziewicz-Motowidło S; Berezowska I; Schiller PW
    Adv Exp Med Biol; 2009; 611():489-90. PubMed ID: 19400278
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and receptor binding of opioid peptide analogues containing beta3-homo-amino acids.
    Wilczyńska D; Kosson P; Kwasiborska M; Ejchart A; Olma A
    J Pept Sci; 2009 Nov; 15(11):777-82. PubMed ID: 19787815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding to delta and mu opioid receptors by deltorphin I/II analogues modified at the Phe3 and Asp4/Glu4 side chains: a report of 32 new analogues and a QSAR study.
    Schullery SE; Mohammedshah T; Makhlouf H; Marks EL; Wilenkin BS; Escobar S; Mousigian C; Heyl DL
    Bioorg Med Chem; 1997 Dec; 5(12):2221-34. PubMed ID: 9459020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics conformations of deltorphin analogues advocate delta opioid binding site models.
    Bryant SD; Attila M; Salvadori S; Guerrini R; Lazarus LH
    Pept Res; 1994; 7(4):175-84. PubMed ID: 7696838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
    Gyires K; Rónai AZ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution on the Phe3 aromatic ring in cyclic delta opioid receptor-selective dermorphin/deltorphin tetrapeptide analogues: electronic and lipophilic requirements for receptor affinity.
    Heyl DL; Mosberg HI
    J Med Chem; 1992 May; 35(9):1535-41. PubMed ID: 1315870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superpotent [Dmt¹] dermorphin tetrapeptides containing the 4-aminotetrahydro-2-benzazepin-3-one scaffold with mixed μ/δ opioid receptor agonistic properties.
    Vandormael B; Fourla DD; Gramowski-Voss A; Kosson P; Weiss DG; Schröder OH; Lipkowski A; Georgoussi Z; Tourwé D
    J Med Chem; 2011 Nov; 54(22):7848-59. PubMed ID: 21978284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
    Arttamangkul S; Ishmael JE; Murray TF; Grandy DK; DeLander GE; Kieffer BL; Aldrich JV
    J Med Chem; 1997 Apr; 40(8):1211-8. PubMed ID: 9111295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-induced internalization of selective peptidic mu and delta opioid ligands.
    Gaudriault G; Nouel D; Dal Farra C; Beaudet A; Vincent JP
    J Biol Chem; 1997 Jan; 272(5):2880-8. PubMed ID: 9006932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.